Mochi Health Tirzepatide Review
Released: Last reviewed: Provider data verified: Updated:
Mochi Health offers compounded tirzepatide with NP-led intake. Mid-range pricing (semaglutide $139/month all-in; tirzepatide $169/month all-in) and 503A pharmacy fulfillment. Limited pharmacy disclosure beyond 503A.
Mochi Health at a glance
| Pricing | semaglutide $139/mo all-in; tirzepatide $169/mo all-in |
|---|---|
| Pharmacy | 503A only |
| Clinician | NP |
| States | 50 states |
| Editorial score | 73 / 100 |
About Mochi Health
Mochi Health is a physician-led telehealth weight loss program emphasizing affordable compounded GLP-1 access. The platform targets the cash-pay segment with subscription pricing and integrated provider oversight.
Clinical & business model
Subscription model with compounded GLP-1 focus. Patient intake includes medical history, BMI verification, and clinical assessment. Ongoing care includes asynchronous messaging and dose adjustment as appropriate. Pricing is positioned competitively in the cash-pay compounded segment.
What Mochi Health does well
- Competitive cash-pay pricing for compounded GLP-1s
- Physician-led clinical model
- Subscription-based predictable monthly cost
- Operational scale in the cash-pay segment
Trade-offs to consider
- Less public detail on pharmacy network composition
- Coaching depth is less emphasized than higher-touch programs
- Compounded-only focus means brand-name seekers need to go elsewhere
Who Mochi Health is best for
Cash-pay patients prioritizing predictable monthly cost for compounded GLP-1 access.
How it compares to NexLife (our #1 pick)
NexLife (94/100) and Mochi Health (#9 in our ranking) compete in similar cash-pay segments. NexLife's advantages include explicit named-pharmacy disclosure on its plan pages, MD/DO-supervised oversight and Care 360 coaching included; laboratory review is not stated on its pages (corrected September 17, 2026).
Frequently asked questions
Does Mochi Health offer brand-name GLP-1s?
Mochi Health's focus is on compounded GLP-1 access for the cash-pay segment. Patients seeking brand-name Wegovy or Zepbound generally pursue insurance-based pathways elsewhere.
Is Mochi Health available nationwide?
Mochi Health operates in most states, subject to state-specific telehealth and prescribing requirements. Confirm availability in your state during the intake process.
How does Mochi Health price its programs?
Mochi Health uses subscription pricing in the cash-pay compounded segment. Specific rates have varied with promotional periods and program tier.
NexLife Tirzepatide
Compounded semaglutide + tirzepatide · MD/DO oversight
*12-month plan · flat rate · all titration doses
- From $139/mo (12-mo plan)
- three named pharmacies
- MD/DO-supervised
- Care360 coaching included
- Provider oversight included
- LegitScript-certified
- Availability varies by state
Or call (949) 818-8000
Primary sources
- FDA: Concerns with unapproved GLP-1 drugs used for weight loss (current as of October 1, 2026)
- FDA: Policies for compounders as national GLP-1 supply stabilizes (updated April 1, 2026)
- FDA: Warning letters to 30 telehealth companies over compounded GLP-1 marketing (March 3, 2026)
- FDA: Compounding and the FDA — questions and answers
- FDA: Proposal to exclude semaglutide, tirzepatide and liraglutide from the 503B bulks list (April 30, 2026)
- Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med 2022